Aghaei-Ghareh-Bolagh B, Mukherjee S, Lockley K M, Mithieux S M, Wang Z, Emmerson S, Darzi S, Gargett C E, Weiss A S
Charles Perkins Centre, University of Sydney, NSW, 2006, Australia.
School of Life and Environmental Sciences, University of Sydney, NSW, 2006, Australia.
Mater Today Bio. 2020 Oct 13;8:100081. doi: 10.1016/j.mtbio.2020.100081. eCollection 2020 Sep.
Pelvic organ prolapse is a common condition that affects 1 in 4 women across all age groups. It is mainly caused by vaginal birth injury and can be exacerbated by obesity and increased age. Until recently, treatment strategies often used non-degradable synthetic meshes for reconstructive surgery. However, owing to their frequent, unacceptable rate of adverse events such as mesh erosion, transvaginal meshes have been banned in many countries. Recent reports have highlighted the urgent need for biocompatible design of meshes for a safe and effective treatment in the long term. This study reports the design and evaluation of a novel, elastin based degradable mesh using an ovine model of POP as a potential surgical treatment. Elastin is a protein component of the ECM and provides elasticity to tissues throughout the body. Tropoelastin, the monomer subunit of elastin, has been used with success in electrospun constructs as it is a naturally cell interactive polymer. Biomaterials that incorporate tropoelastin support cell attachment and proliferation, and have been proven to encourage elastogenesis and angiogenesis and . The biological properties of tropoelastin were combined with the physical properties of PCL, a degradable synthetic polymer, with the aim of producing, characterizing and assessing the performance of continuous tropoelastin:PCL electrospun yarns. Using a modified spinneret electrospinning system and adjusting settings based on relative humidity, four blends of tropoelastin:PCL yarns were fabricated with concentration ratios of 75:25, 50:50, 25:75 and 0:100. Yarns were assessed for ease of manufacture, fibrous architecture, protein/polymer content, yarn stability - including initial tropoelastin release, mechanical strength, and ability to support cell growth. Based on overall favorable properties, a mesh woven from the 50:50 tropoelastin:PCL yarn was implanted into the vagina of a parous ewe with vaginal wall weakness as a model of pelvic organ prolapse. This mesh showed excellent integration with new collagen deposition by SEM and a predominant M2 macrophage response with few pro-inflammatory M1 macrophages after 30 days. The woven tropoelastin:PCL electrospun mesh shows potential as an alternative to non-degradable, synthetic pelvic organ prolapse mesh products.
盆腔器官脱垂是一种常见病症,影响着所有年龄组中四分之一的女性。它主要由阴道分娩损伤引起,肥胖和年龄增长会使其加重。直到最近,治疗策略通常在重建手术中使用不可降解的合成网片。然而,由于诸如网片侵蚀等不良事件的发生率高且不可接受,经阴道网片在许多国家已被禁止使用。最近的报告强调了迫切需要对网片进行生物相容性设计,以便进行长期安全有效的治疗。本研究报告了一种新型的、基于弹性蛋白的可降解网片的设计与评估,该网片以绵羊盆腔器官脱垂模型作为一种潜在的手术治疗方法。弹性蛋白是细胞外基质的一种蛋白质成分,为全身组织提供弹性。原弹性蛋白是弹性蛋白的单体亚基,已成功用于电纺构建体,因为它是一种天然的细胞相互作用聚合物。包含原弹性蛋白的生物材料支持细胞附着和增殖,并已被证明能促进弹性生成和血管生成。将原弹性蛋白的生物学特性与可降解合成聚合物聚己内酯(PCL)的物理特性相结合,目的是制备、表征和评估连续的原弹性蛋白:PCL电纺丝的性能。使用改良的喷丝头电纺系统,并根据相对湿度调整设置,制备了四种浓度比为75:25、50:50、25:75和0:100的原弹性蛋白:PCL纺丝。对纺丝的制造难易程度、纤维结构、蛋白质/聚合物含量、纺丝稳定性(包括初始原弹性蛋白释放、机械强度和支持细胞生长的能力)进行了评估。基于总体良好的性能,将由50:50的原弹性蛋白:PCL纺丝编织而成的网片植入一只经产母羊的阴道,该母羊阴道壁薄弱,作为盆腔器官脱垂的模型。30天后,通过扫描电子显微镜观察,该网片显示出与新的胶原沉积良好整合,并且主要是M2巨噬细胞反应,促炎性M1巨噬细胞很少。编织的原弹性蛋白:PCL电纺网片显示出作为不可降解的合成盆腔器官脱垂网片产品替代品的潜力。